Abbott Russia

Aktivs

As of April 2018, more than 3,000 employees work in Abbott's office in Moscow, as well as in a branch in St. Petersburg and throughout Russia and at Veropharm enterprises in Volginsky (Vladimir region), Belgorod and Voronezh.

History

2021: Opening of the Scientific and Technical Production Center on the basis of Veropharm

On October 19, 2021, Abbott announced the opening of the Scientific and Technical Production Center at the Veropharm production site (Abbott Group) in Belgorod. Read more here.

2018

Opening of full-cycle didrogesterone production in Belgorod

On April 10, 2018, Abbott announced the opening of a full-cycle production line at the Veropharm plant (part of the Abbott group) in Belgorod. The goal of the launch, as explained in the company, is to localize the production of Abbott to maintain female reproductive health, which meets the strategic tasks of the state to increase the birth rate in Russia. Read more here.

Starlink Media Service Contract

In early 2018, according to the results of the tender, Abbott Laboratories extended the contract with Starlink (Publicis Media) for full media service of the Similac, Maloezhka, Irs19, Imudon, Dufalak, Duspatalin, Dufamishki, Creon and Marimer brands.

2016:10% drop in revenue in Russia to $483 million

In June 2016, Abbott Laboratories released its annual financial report, according to which developed and fast-growing markets divide Abbott's revenue by a ratio of 50% by 50%. The latter include Russia, where the company's sales fell in the fiscal year to $483 million from $536 million a year earlier (a 10% decline). Throughout the company's product line, sales in Russia account for about 2.4%. At the same time, the Russian market occupies 10% of the manufacturer's revenue from sales of medicines in the so-called fast-growing markets. Latin America (32%) and India (21%) bring more income.

By the end of June 2016, the division in Russia employs 3.5 thousand people. At this time, Abbott is recording an increase in the number of laboratory optimization projects in Russia. Dmitry Paramonov, Managing Director of the Diagnostic Division of Abbott in Russia and the CIS:

"In 2012-2013, Abbott took part in only a few projects to optimize laboratories in Russia, today we have more than a dozen such projects. For example, projects to centralize laboratories in Oktyabrsky and Birsk (Bashkiria), where we took part, were successfully completed. "

2014: Elena Kartasheva - CEO

On July 1, 2014, it was announced that Leonid Parshenkov, who served as CEO of Abbott in Russia, was appointed Regional Director for Africa for Abbott.

As the head of Abbott in Russia, Leonid Parshenkov was replaced by Elena Kartasheva.

2010: Leonid Parshenkov appointed CEO

After the acquisition of Solvay-Pharma by Abbott, Leonid Parshenkov took over as CEO of Abbott in Russia.

1970s: First deliveries to the USSR

Abbott began deliveries to the USSR in the late 1970s.